nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—tongue—hypothyroidism	0.0773	0.191	CbGeAlD
Roflumilast—PDE4D—heart—hypothyroidism	0.0259	0.0639	CbGeAlD
Roflumilast—PDE4A—heart—hypothyroidism	0.0229	0.0565	CbGeAlD
Roflumilast—PDE4D—adrenal gland—hypothyroidism	0.0193	0.0477	CbGeAlD
Roflumilast—PDE4D—thyroid gland—hypothyroidism	0.0186	0.046	CbGeAlD
Roflumilast—PDE4D—female gonad—hypothyroidism	0.018	0.0444	CbGeAlD
Roflumilast—PDE4A—adrenal gland—hypothyroidism	0.0171	0.0422	CbGeAlD
Roflumilast—PDE4A—thyroid gland—hypothyroidism	0.0165	0.0407	CbGeAlD
Roflumilast—PDE4D—testis—hypothyroidism	0.016	0.0394	CbGeAlD
Roflumilast—PDE4A—female gonad—hypothyroidism	0.0159	0.0393	CbGeAlD
Roflumilast—PDE4D—liver—hypothyroidism	0.0151	0.0373	CbGeAlD
Roflumilast—PDE4D—cerebellum—hypothyroidism	0.0147	0.0364	CbGeAlD
Roflumilast—PDE4A—testis—hypothyroidism	0.0141	0.0349	CbGeAlD
Roflumilast—Renal failure acute—Liotrix—hypothyroidism	0.014	0.0285	CcSEcCtD
Roflumilast—Weight decreased—Dextrothyroxine—hypothyroidism	0.0138	0.0279	CcSEcCtD
Roflumilast—Weight decreased—Levothyroxine—hypothyroidism	0.0138	0.0279	CcSEcCtD
Roflumilast—PDE4B—heart—hypothyroidism	0.0136	0.0337	CbGeAlD
Roflumilast—PDE4A—cerebellum—hypothyroidism	0.013	0.0322	CbGeAlD
Roflumilast—PDE4D—TSH signaling pathway—PAX8—hypothyroidism	0.0122	0.119	CbGpPWpGaD
Roflumilast—PDE4B—gonad—hypothyroidism	0.0117	0.0289	CbGeAlD
Roflumilast—PDE4B—pituitary gland—hypothyroidism	0.0114	0.0281	CbGeAlD
Roflumilast—Tension—Dextrothyroxine—hypothyroidism	0.0104	0.0211	CcSEcCtD
Roflumilast—Tension—Levothyroxine—hypothyroidism	0.0104	0.0211	CcSEcCtD
Roflumilast—Nervousness—Levothyroxine—hypothyroidism	0.0103	0.0209	CcSEcCtD
Roflumilast—Nervousness—Dextrothyroxine—hypothyroidism	0.0103	0.0209	CcSEcCtD
Roflumilast—PDE4B—adrenal gland—hypothyroidism	0.0102	0.0251	CbGeAlD
Roflumilast—PDE4B—blood—hypothyroidism	0.0102	0.0251	CbGeAlD
Roflumilast—Weight decreased—Liotrix—hypothyroidism	0.0101	0.0205	CcSEcCtD
Roflumilast—Tremor—Dextrothyroxine—hypothyroidism	0.00992	0.0202	CcSEcCtD
Roflumilast—Tremor—Levothyroxine—hypothyroidism	0.00992	0.0202	CcSEcCtD
Roflumilast—PDE4B—thyroid gland—hypothyroidism	0.00983	0.0243	CbGeAlD
Roflumilast—Angioedema—Dextrothyroxine—hypothyroidism	0.00968	0.0197	CcSEcCtD
Roflumilast—Angioedema—Levothyroxine—hypothyroidism	0.00968	0.0197	CcSEcCtD
Roflumilast—PDE4B—female gonad—hypothyroidism	0.0095	0.0234	CbGeAlD
Roflumilast—Palpitations—Dextrothyroxine—hypothyroidism	0.00936	0.019	CcSEcCtD
Roflumilast—Palpitations—Levothyroxine—hypothyroidism	0.00936	0.019	CcSEcCtD
Roflumilast—Anxiety—Dextrothyroxine—hypothyroidism	0.00899	0.0183	CcSEcCtD
Roflumilast—Anxiety—Levothyroxine—hypothyroidism	0.00899	0.0183	CcSEcCtD
Roflumilast—PDE4B—testis—hypothyroidism	0.00842	0.0208	CbGeAlD
Roflumilast—PDE4B—liver—hypothyroidism	0.00796	0.0197	CbGeAlD
Roflumilast—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00788	0.016	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00788	0.016	CcSEcCtD
Roflumilast—Insomnia—Dextrothyroxine—hypothyroidism	0.00782	0.0159	CcSEcCtD
Roflumilast—Insomnia—Levothyroxine—hypothyroidism	0.00782	0.0159	CcSEcCtD
Roflumilast—PDE4B—cerebellum—hypothyroidism	0.00778	0.0192	CbGeAlD
Roflumilast—Tension—Liotrix—hypothyroidism	0.00764	0.0155	CcSEcCtD
Roflumilast—Dysgeusia—Liotrix—hypothyroidism	0.00763	0.0155	CcSEcCtD
Roflumilast—Nervousness—Liotrix—hypothyroidism	0.00757	0.0154	CcSEcCtD
Roflumilast—Fatigue—Levothyroxine—hypothyroidism	0.00745	0.0151	CcSEcCtD
Roflumilast—Fatigue—Dextrothyroxine—hypothyroidism	0.00745	0.0151	CcSEcCtD
Roflumilast—Tremor—Liotrix—hypothyroidism	0.0073	0.0148	CcSEcCtD
Roflumilast—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00712	0.0145	CcSEcCtD
Roflumilast—Feeling abnormal—Levothyroxine—hypothyroidism	0.00712	0.0145	CcSEcCtD
Roflumilast—Angioedema—Liotrix—hypothyroidism	0.00712	0.0145	CcSEcCtD
Roflumilast—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00707	0.0144	CcSEcCtD
Roflumilast—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00707	0.0144	CcSEcCtD
Roflumilast—Palpitations—Liotrix—hypothyroidism	0.00688	0.014	CcSEcCtD
Roflumilast—Urticaria—Levothyroxine—hypothyroidism	0.00687	0.0139	CcSEcCtD
Roflumilast—Urticaria—Dextrothyroxine—hypothyroidism	0.00687	0.0139	CcSEcCtD
Roflumilast—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00683	0.0139	CcSEcCtD
Roflumilast—Abdominal pain—Levothyroxine—hypothyroidism	0.00683	0.0139	CcSEcCtD
Roflumilast—Anxiety—Liotrix—hypothyroidism	0.00661	0.0134	CcSEcCtD
Roflumilast—Infection—Liotrix—hypothyroidism	0.00632	0.0128	CcSEcCtD
Roflumilast—Asthenia—Dextrothyroxine—hypothyroidism	0.0062	0.0126	CcSEcCtD
Roflumilast—Asthenia—Levothyroxine—hypothyroidism	0.0062	0.0126	CcSEcCtD
Roflumilast—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00591	0.012	CcSEcCtD
Roflumilast—Diarrhoea—Levothyroxine—hypothyroidism	0.00591	0.012	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00579	0.0118	CcSEcCtD
Roflumilast—Insomnia—Liotrix—hypothyroidism	0.00575	0.0117	CcSEcCtD
Roflumilast—Decreased appetite—Liotrix—hypothyroidism	0.00553	0.0112	CcSEcCtD
Roflumilast—Vomiting—Dextrothyroxine—hypothyroidism	0.0055	0.0112	CcSEcCtD
Roflumilast—Vomiting—Levothyroxine—hypothyroidism	0.0055	0.0112	CcSEcCtD
Roflumilast—Fatigue—Liotrix—hypothyroidism	0.00548	0.0111	CcSEcCtD
Roflumilast—Rash—Dextrothyroxine—hypothyroidism	0.00545	0.0111	CcSEcCtD
Roflumilast—Rash—Levothyroxine—hypothyroidism	0.00545	0.0111	CcSEcCtD
Roflumilast—Dermatitis—Dextrothyroxine—hypothyroidism	0.00545	0.0111	CcSEcCtD
Roflumilast—Dermatitis—Levothyroxine—hypothyroidism	0.00545	0.0111	CcSEcCtD
Roflumilast—Constipation—Liotrix—hypothyroidism	0.00544	0.011	CcSEcCtD
Roflumilast—Headache—Dextrothyroxine—hypothyroidism	0.00542	0.011	CcSEcCtD
Roflumilast—Headache—Levothyroxine—hypothyroidism	0.00542	0.011	CcSEcCtD
Roflumilast—PDE4D—TSH signaling pathway—TSHB—hypothyroidism	0.00531	0.0518	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—TSHR—hypothyroidism	0.00531	0.0518	CbGpPWpGaD
Roflumilast—Feeling abnormal—Liotrix—hypothyroidism	0.00524	0.0106	CcSEcCtD
Roflumilast—Gastrointestinal pain—Liotrix—hypothyroidism	0.0052	0.0106	CcSEcCtD
Roflumilast—Nausea—Levothyroxine—hypothyroidism	0.00513	0.0104	CcSEcCtD
Roflumilast—Nausea—Dextrothyroxine—hypothyroidism	0.00513	0.0104	CcSEcCtD
Roflumilast—Urticaria—Liotrix—hypothyroidism	0.00505	0.0103	CcSEcCtD
Roflumilast—Abdominal pain—Liotrix—hypothyroidism	0.00503	0.0102	CcSEcCtD
Roflumilast—Hypersensitivity—Liotrix—hypothyroidism	0.00468	0.00952	CcSEcCtD
Roflumilast—Asthenia—Liotrix—hypothyroidism	0.00456	0.00927	CcSEcCtD
Roflumilast—Diarrhoea—Liotrix—hypothyroidism	0.00435	0.00884	CcSEcCtD
Roflumilast—Dizziness—Liotrix—hypothyroidism	0.0042	0.00854	CcSEcCtD
Roflumilast—Vomiting—Liotrix—hypothyroidism	0.00404	0.00821	CcSEcCtD
Roflumilast—Rash—Liotrix—hypothyroidism	0.00401	0.00814	CcSEcCtD
Roflumilast—Dermatitis—Liotrix—hypothyroidism	0.00401	0.00814	CcSEcCtD
Roflumilast—Headache—Liotrix—hypothyroidism	0.00398	0.00809	CcSEcCtD
Roflumilast—Nausea—Liotrix—hypothyroidism	0.00378	0.00767	CcSEcCtD
Roflumilast—PDE4C—G alpha (s) signalling events—TSHB—hypothyroidism	0.00369	0.0359	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—TSHR—hypothyroidism	0.00369	0.0359	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—TSHB—hypothyroidism	0.00321	0.0312	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—TSHR—hypothyroidism	0.00321	0.0312	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00305	0.0297	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00305	0.0297	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—TSHR—hypothyroidism	0.00283	0.0275	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—TSHB—hypothyroidism	0.00283	0.0275	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—AVP—hypothyroidism	0.00217	0.0212	CbGpPWpGaD
Roflumilast—PDE4C—Opioid Signalling—POMC—hypothyroidism	0.00203	0.0198	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—AVP—hypothyroidism	0.00189	0.0184	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—AVP—hypothyroidism	0.0018	0.0175	CbGpPWpGaD
Roflumilast—PDE4D—Opioid Signalling—POMC—hypothyroidism	0.00177	0.0172	CbGpPWpGaD
Roflumilast—PDE4A—Opioid Signalling—POMC—hypothyroidism	0.00168	0.0164	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—AVP—hypothyroidism	0.00167	0.0162	CbGpPWpGaD
Roflumilast—PDE4B—Opioid Signalling—POMC—hypothyroidism	0.00156	0.0152	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—POMC—hypothyroidism	0.00144	0.0141	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—POMC—hypothyroidism	0.00126	0.0122	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—POMC—hypothyroidism	0.0012	0.0116	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—POMC—hypothyroidism	0.00111	0.0108	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TRH—hypothyroidism	0.000848	0.00826	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TRH—hypothyroidism	0.00077	0.0075	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TSHR—hypothyroidism	0.000756	0.00736	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TSHB—hypothyroidism	0.000756	0.00736	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TRH—hypothyroidism	0.000739	0.00719	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TRH—hypothyroidism	0.000703	0.00685	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TSHB—hypothyroidism	0.000687	0.00669	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TSHR—hypothyroidism	0.000687	0.00669	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TRH—hypothyroidism	0.000671	0.00653	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TSHB—hypothyroidism	0.000658	0.00641	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TSHR—hypothyroidism	0.000658	0.00641	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TRH—hypothyroidism	0.00065	0.00633	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TRH—hypothyroidism	0.000638	0.00622	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TSHB—hypothyroidism	0.000627	0.0061	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TSHR—hypothyroidism	0.000627	0.0061	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TSHB—hypothyroidism	0.000598	0.00582	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TSHR—hypothyroidism	0.000598	0.00582	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TRH—hypothyroidism	0.000591	0.00575	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TSHB—hypothyroidism	0.00058	0.00565	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TSHR—hypothyroidism	0.00058	0.00565	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TSHB—hypothyroidism	0.000569	0.00554	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TSHR—hypothyroidism	0.000569	0.00554	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CLTC—hypothyroidism	0.000527	0.00513	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TSHB—hypothyroidism	0.000526	0.00513	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TSHR—hypothyroidism	0.000526	0.00513	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—VAV3—hypothyroidism	0.000463	0.00451	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CLTC—hypothyroidism	0.000458	0.00446	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TRH—hypothyroidism	0.000455	0.00443	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AVP—hypothyroidism	0.000446	0.00434	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CLTC—hypothyroidism	0.000436	0.00425	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—VAV3—hypothyroidism	0.00042	0.00409	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TSHB—hypothyroidism	0.000406	0.00395	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TSHR—hypothyroidism	0.000406	0.00395	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AVP—hypothyroidism	0.000405	0.00394	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CLTC—hypothyroidism	0.000404	0.00393	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—VAV3—hypothyroidism	0.000403	0.00392	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TRH—hypothyroidism	0.000396	0.00386	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AVP—hypothyroidism	0.000388	0.00378	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—VAV3—hypothyroidism	0.000383	0.00373	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TRH—hypothyroidism	0.000377	0.00367	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AVP—hypothyroidism	0.000369	0.0036	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—VAV3—hypothyroidism	0.000366	0.00356	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SH2B3—hypothyroidism	0.000362	0.00352	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—VAV3—hypothyroidism	0.000355	0.00345	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TSHB—hypothyroidism	0.000353	0.00344	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TSHR—hypothyroidism	0.000353	0.00344	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AVP—hypothyroidism	0.000352	0.00343	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TRH—hypothyroidism	0.000349	0.0034	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—VAV3—hypothyroidism	0.000348	0.00339	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AVP—hypothyroidism	0.000342	0.00333	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TSHB—hypothyroidism	0.000336	0.00327	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TSHR—hypothyroidism	0.000336	0.00327	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AVP—hypothyroidism	0.000335	0.00327	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—VAV3—hypothyroidism	0.000322	0.00314	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SH2B3—hypothyroidism	0.000315	0.00307	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TSHB—hypothyroidism	0.000311	0.00303	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TSHR—hypothyroidism	0.000311	0.00303	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AVP—hypothyroidism	0.00031	0.00302	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SH2B3—hypothyroidism	0.0003	0.00292	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—POMC—hypothyroidism	0.000296	0.00288	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SH2B3—hypothyroidism	0.000277	0.0027	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—POMC—hypothyroidism	0.000269	0.00262	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRL—hypothyroidism	0.000268	0.00261	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—POMC—hypothyroidism	0.000258	0.00251	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VAV3—hypothyroidism	0.000248	0.00242	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—POMC—hypothyroidism	0.000245	0.00239	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AVP—hypothyroidism	0.000239	0.00233	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—POMC—hypothyroidism	0.000234	0.00228	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRL—hypothyroidism	0.000234	0.00227	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—POMC—hypothyroidism	0.000227	0.00221	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—POMC—hypothyroidism	0.000223	0.00217	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRL—hypothyroidism	0.000222	0.00216	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VAV3—hypothyroidism	0.000216	0.0021	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AVP—hypothyroidism	0.000208	0.00203	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—hypothyroidism	0.000206	0.00201	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRL—hypothyroidism	0.000206	0.002	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VAV3—hypothyroidism	0.000206	0.002	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AVP—hypothyroidism	0.000198	0.00193	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VAV3—hypothyroidism	0.00019	0.00185	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AVP—hypothyroidism	0.000183	0.00179	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—hypothyroidism	0.000159	0.00155	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—hypothyroidism	0.000153	0.00149	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—hypothyroidism	0.000138	0.00135	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—hypothyroidism	0.000133	0.0013	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—hypothyroidism	0.000132	0.00128	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—hypothyroidism	0.000127	0.00123	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—hypothyroidism	0.000122	0.00119	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—hypothyroidism	0.000117	0.00114	CbGpPWpGaD
